secwatch.observer — SEC 8-K summary
======================================

Issuer:     DEXCOM INC (DXCM)
CIK:        0001093557
Form:       8-K
Filed at:   2023-06-26T23:59:59+00:00
Accession:  0001093557-23-000157
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dexcom raises 2025 revenue target to $4.6-5.1B, operating margin to 21%
-----------------------------------------------------------------------

- 2025 revenue target raised to ~$4.6-5.1B from prior $4.0-4.5B.
- Non-GAAP operating profit margin target raised to 21% (from 20%).
- Adjusted EBITDA margin target raised to 31% (from 30%).
- Non-GAAP gross profit margin target unchanged at 65%.
- CEO Kevin Sayer cites strong performance and efficient business model.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1093557/000109355723000157/0001093557-23-000157-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1093557/000109355723000157/dxcm-20230623.htm
  HTML page:      https://secwatch.observer/filing/0001093557-23-000157

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer